Home > Insider Trading > Filing (0001209191-19-002919)

Filing Details

Accession Number:: 0001209191-19-002919
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-01-08 20:14:54
Reporting Period:: 2019-01-05

Accepted Time:: 2019-01-08 20:14:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1142750	Amn Healthcare Services Inc	AMN	Services-Help Supply Services (7363)	061500476

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1158584	R Susan Salka	8840 Cypress Waters Blvd., Suite 300 Coppell TX 75019	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-01-05	24,750	$0.00	197,707	No	4	A	Direct
Common Stock	Disposition	2019-01-05	9,821	$55.92	187,886	No	4	F	Direct
Common Stock	Acquisiton	2019-01-08	77,580	$8.78	265,466	No	4	M	Direct
Common Stock	Disposition	2019-01-08	38,028	$55.05	227,438	No	4	D	Direct
Common Stock	Disposition	2019-01-08	39,552	$57.90	187,886	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	F	Direct
No	4	M	Direct
No	4	D	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Rights	Disposition	2019-01-08	77,580	$0.00	77,580	$8.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
116,369		2020-02-02	No	4	M	Direct

Footnotes

The acquisition of common stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2016. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2015 for the 3-year period beginning on January 1, 2016 and ended December 31, 2018 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 3, 2019. The Company's Relative TSR measured in the 84th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award, were deemed earned and vested.
Number of shares withheld for tax purposes.
A Stock-Settled Appreciation Right ("SSAR") entitles the Grantee to the right to receive shares of AMN's Common Stock ("Stock") having a value equal to the excess of the Fair Market Value of the closing price of the Stock on the trading day prior to the date of exercise over the Exercise Price multiplied by the number of SSARs exercised. This number set forth in this row represents the difference between the number of SSARs exercised (77,580) and the number of shares of Stock issued as a result of the exercise (39,552).
The sale of 39,552 shares of AMN Common Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in this row represents a weighted average price of $57.8953 per share. These shares were sold in multiple transactions at prices ranging from $57.305 to $58.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The exercise of derivative securities reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The SSARs set forth in this row were granted on February 2, 2010 pursuant to the AMN Healthcare Equity Plan and vested in three equal installments on the first, second and third anniversary of the grant date.